INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Pr Camiel BOON

In this page

Member info

Pr Camiel BOON

Representative

Netherlands

Working Group Leader: Research (TWG8)
Other Working Group(s): Retinal Rare Eye Diseases (WG1), Pediatric Ophthalmology Rare Diseases (WG3), Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Research (TWG8), National Integration (TWG9)

Team

Dr Axel PETZOLD

Netherlands

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Lucas Wenninger

Netherlands

Neuro-Ophthalmology Rare Diseases (WG2)
See more

HCP Center

AMC / LUMC are modern university medical centers for research, education and patient care with a high quality profile and a strong scientific...

contact

Amsterdam University Medical Center / Leiden University Medical Center

Albinusdreef 2
2333 ZA Leiden
Netherlands

Clinical trials

NCT05537220 Recruiting, Active

NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa

Interventional
See the trial
voir la fiche

NCT04671433 Active, Not recruiting

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT04794101 Active, Not recruiting

Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT03079141 Unknown

Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.

Interventional
See the trial
voir la fiche

A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral soraprazan in Stargardt disease

Interventional
See the trial
voir la fiche
NCT06114537 Completed

Prospective Clinical Trial to Evaluate the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis: The AXIS Trial

Interventional
See the trial
voir la fiche
NCT06627179 Recruiting, Active

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Interventional
See the trial
voir la fiche

Scientific publications

Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy

Van de Sompele et al. used multiomics profiling and in vitro and in vivo enhancer assays to dissect the regulatory mechanisms underlying North...

Novel Clinical Observations and Genetic Spectrum in 340 Patients

In most patients, XLRS showed a slow deterioration starting in the second decade of life, suggesting an optimal window of opportunity for...

Outcome of Cataract Surgery in Patients With Retinitis Pigmentosa

To assess the visual outcome of cataract surgery in patients with retinitis pigmentosa...

The Natural History of Leber Congenital Amaurosis and ConeeRod Dystrophy Associated with Variants in the GUCY2D Gene

Leber congenital amaurosis associated with GUCY2D caused severe congenital visual impairment with relatively intact macular anatomy on funduscopy...

Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1

KCNV2-associated retinopathy: genotype-phenotype correlations – KCNV2 study group report 3

Patients with missense alterations had better BCVA and greater structural integrity. This is important for patient prognostication and...

Long-Term Follow-Up of Retinal Degenerations Associated With LRAT Mutations and Their Comparability to Phenotypes Associated With RPE65 Mutations

To investigate the natural history in patients with LRAT-associated retinal degenerations (RDs), in the advent of clinical trials testing...

Central serous chorioretinopathy: Towards an evidence-based treatment guideline

To date, no consensus has been reached regarding the classification of CSC, and a wide variety of interventions have been proposed, reflecting the...

Syndromic Retinitis Pigmentosa

Clinical, Genetic, and Histopathological Characteristics of CRX-associated Retinal Dystrophies

Genetic Testing of Patients with Inherited Retinal Diseases in the European Countries: An International Survey by the European Vision Institute

Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis

Our data indicate that treatment with (oral) CAI may be beneficial for short-term management of CFC in patients with...

Quality of life in patients with CRB1-associated retinal dystrophies: A longitudinal study